Business · 1 sources covering this

Could supplements be the next big opportunity in the GLP-1 weight-loss drug boom?

Novonesis is exploring whether gut health supplements could benefit patients taking GLP-1 weight-loss drugs, opening up a potentially lucrative new market.

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

0 L · 0 C · 1 R

How 1 sources are covering this

CNBCLean R·4h ago
Could supplements be the next big opportunity in the GLP-1 weight-loss drug boom?
Novonesis is exploring whether gut health supplements could benefit patients taking GLP-1 weight-loss drugs, opening up a potentially lucrative new market.
Read at CNBC →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/1af1cf7fcae569f852d7f017d36ec9e7dd844446"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Could supplements be the next big opportunity in the GLP-1 weight-loss drug boom?"></iframe>

Could supplements be the next big opportunity in the GLP-1 weight-loss drug boom?

How 1 sources are covering this

Could supplements be the next big opportunity in the GLP-1 weight-loss drug boom?

More from Business

Dow rallies 900 points, Nasdaq jumps 2% as stocks climb out of postelection slump: Live updates

Trump questions midterm election results, revives voting-machine conspiracy

This software stock is bucking the latest tech rout and breaking out

U.S. Commerce Dept. Inquiry Into Megaspeed Was Halted After Nvidia Intervention

Reader

Trust & legal

Across the network